FDA Approves Treatment for Yeast Ear Infections in Dogs

U.S. Food and Drug Administration sent this bulletin at 03/15/2024 01:02 PM EDT

If your email program has trouble displaying this email, view as a webpage.
US Food and Drug Administration

FDA Approves Treatment for Yeast Ear Infections in Dogs

Today the U.S. Food and Drug Administration approved DuOtic (terbinafine and betamethasone acetate otic gel) for the treatment of otitis externa in dogs, associated with susceptible strains of yeast (Malassezia pachydermatis).

DuOtic is the first FDA-approved animal drug intended to treat yeast-only otitis externa in dogs. DuOtic is also the first otic drug intended to treat otitis externa that does not contain an antibiotic. This allows veterinarians to focus treatment and avoid using antibiotics when dogs have diagnosed yeast-only ear infections.

Read More Button


You are subscribed to updates from FDA's Center for Veterinary Medicine.